Understanding male breast cancer at Methodist Health System
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Methodist Health System · NCT06133647
This study looks at male breast cancer patients at Methodist Health System to learn more about their experiences and outcomes, so doctors can better understand and treat this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Methodist Health System (other) |
| Locations | 2 sites (Dallas, Texas and 1 other locations) |
| Trial ID | NCT06133647 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on the demographics, characteristics, and outcomes of male breast cancer patients at Methodist Health System. By focusing on cases of ductal carcinoma in situ and invasive lobular breast carcinoma, the study seeks to fill the gap in clinical data regarding male breast cancer, which is often managed based on female breast cancer data. The findings will help identify unique aspects of male breast cancer and potentially guide future treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are males aged 18 and older diagnosed with ductal carcinoma in situ or invasive lobular carcinoma.
Not a fit: Patients who are under 18, pregnant, breastfeeding, or incarcerated will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of male breast cancer, ultimately enhancing patient outcomes.
How similar studies have performed: While male breast cancer is rare and under-researched, previous studies have indicated the need for more focused research, suggesting that this approach is novel and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast Exclusion Criteria: * 18 years of age * Prisoners * Pregnant or breastfeeding
Where this trial is running
Dallas, Texas and 1 other locations
- Clinical Research Institute at Methodist Health System — Dallas, Texas, United States (RECRUITING)
- Clinical Research Institute at Methodist Health System — Dallas, Texas, United States (RECRUITING)
Study contacts
- Study coordinator: Colette N Ngo Ndjom, MS
- Email: MHSIRB@mhd.com
- Phone: 214-947-1280
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ductal Carcinoma in Situ, Invasive Lobular Breast Carcinoma